KAYLA BAKANE
NORTH RICHLAND HILLS, TX NPI 1124490073
Browse related groups: TX ABBVIE INC. All categories
General Payments — all program years on this page
$8,751.85
- Category: General Payments
- Program years: PY2021–2024
- Record count: 471
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,759.18 across 96 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,759.18 | 96 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $210.20 | 13 |
| Abbott Laboratories | $198.93 | 10 |
| Lilly USA, LLC | $167.67 | 13 |
| Acerta Pharma LLC | $150.23 | 4 |
| GlaxoSmithKline, LLC. | $145.23 | 7 |
| Amgen Inc. | $144.27 | 14 |
| Corium, Inc. | $115.55 | 4 |
| PFIZER INC. | $109.49 | 7 |
| Novo Nordisk AS | $79.72 | 4 |
| Astellas Pharma US Inc | $77.60 | 5 |
| Genentech USA, Inc. | $69.76 | 1 |
| Medtronic, Inc. | $66.58 | 1 |
| Noven Therapeutics, LLC | $57.60 | 3 |
| Exact Sciences Corporation | $33.86 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $32.12 | 2 |
| Antares Pharma, Inc. | $29.97 | 2 |
| SANOFI-AVENTIS U.S. LLC | $28.89 | 1 |
| Merck Sharp & Dohme Corporation | $14.46 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.58 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.47 | 1 |
By program year
Records — PY2024 (96)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.